Inhibition of prostaglandin F2α by selective cyclooxygenase 2 inhibitors accounts for reduced rat leukocyte migration

Inflammation

Volumn 29, Issue 4-6, 2005, Pages 163-169

  De Menezes, Gustavo Batista ^a   Dos Reis, Webster Glayser Pimenta ^a   Santos, Júlia Maria Moreira ^a   Duarte, Igor Dimitri Gama ^a   De Francischi, Janetti Nogueira ^a,b  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b NONE   (Brazil)

Author keywords

Coxibs; Cyclooxygenases; Inflammation; Leukocyte; Prostaglandin F 2

Indexed keywords

4 [5 (4 CHLOROPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOL 1 YL]BENZENESULFONAMIDE; 5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; CELECOXIB; CHEMOATTRACTANT; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; ESCHERICHIA COLI ENDOTOXIN; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; INDOMETACIN; PIROXICAM; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN SYNTHASE INHIBITOR; ROFECOXIB;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ESCHERICHIA COLI; FEMALE; IMMUNE RESPONSE; IN VIVO STUDY; LEUKOCYTE COUNT; LEUKOCYTE MIGRATION; NEUTROPHIL COUNT; NONHUMAN; PERITONEUM; RAT;

ANIMALS; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; DINOPROST; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; INDOMETHACIN; INJECTIONS, INTRAPERITONEAL; LACTONES; LIPOPOLYSACCHARIDES; NEUTROPHIL INFILTRATION; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; SULFONAMIDES; SULFONES; TIME FACTORS;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 33845390748     PISSN: 03603997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10753-006-9013-z     Document Type: Article

References (28)

1. Hellewell, P. G., and P. M. Henson. 1991. Mechanisms of granulocyte accumulation and emigration in vivo. In: Vascular Endothelium: Interactions with Circulating Cells, Gordon ed. Elsevier, Amsterdam, pp. 143-160.
2. Lin, T. J., R. Garduno, R. T. M. Boudreau, and A. C. Issekutz. 2002. Pseudomonas aeruginosa activates human mast cells to induce neutrophil transendothelial migration via mast cell-derived IL-1 alpha and beta. J. Immunol. 169:4522-4530.
3. 2α, a prostanoid released by endothelial cells activated by hypoxia, is a chemoattractant candidate for neutrophil recruitment. Am. J. Pathol. 159(1):345-357.
4. Lee, W., S. Aitken, J. Sodek, and C. A. McCulloch. 1995. Evidence of a direct relationship between neutrophil collagenase activity and periodontal tissue destruction in vivo: role of active enzyme in human periodontitis. J. Periodontal. Res. 30:23-33.
5. Chan, C. C., S. Boyce, C. Brideau, S. Charleson, W. Cromlish, D. Ethier, et al. 1999. Rofecoxib (Vioxx, MK-0966; 4-(4′-Methylsulfonylphenyl)-3- phenyl-2- (5H)-furanone): a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and Biochemical profiles. J. Pharmacol. Exp. Ther. 290:551-560.
6. Penning, T. B., J. J. Talley, S. R. Bertenshaw, J. S. Carter, P. W. Collins, S. Docter, et al. 1997. Synthesis and biological evaluation of the 1,5-Diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-(5-(4-Methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-y1) benzenesulfonamide (SC-58635, Celecoxib). J. Med. Chem. 40:1347-1365.
7. Kuritz, L., and A. Weaver. 2003. Advances in rheumatology: coxibs and beyond. J. Pain. Symp. Manage. 25S:S6-S20.
8. Whittle, B. J. R. 2003. Gastrointestinal effects of nonsteroidal anti-inflammatory drugs. Fundam. Clin. Pharmacol. 17:301-313.
9. Vane, J. R., Y. S. Bakhle, and R. M. Botting. 1998. Cyclooxygenases 1 and 2. Annu. Rev. Pharmacol. Toxicol. 38:97-120.
10. Francischi, J. N., C. T. Chaves, A. C. L. Moura, A. S. Lima, D. L. Ferreira-Alves, A. O. Rocha, et al. 2002. Selective inhibitors of cyclooxygenase-2 (COX-2) induce hypoalgesia in a rat paw model of inflammation. Br. J. Pharmacol. 137(6):837-844.
11. + channel cascade in the antinociceptive effect of rofecoxib. Eur. J. Pharmacol. 484:193-199.
12. Allcock, G. H., M. Allegra, R. J. Flower, and M. Perreti. 2001. Neutrophil accumulation induced by bacterial lipopolysaccharide: effects of dexamethasone and annexin 1. Clin. Exp. Invest. 123(1):62-67.
13. Muller, W. A. 2002. Leukocyte-endothelial cell interactions in the inflammatory response. Lab. Invest. 82(5):521-533.
14. Smith, C. J., Y. Zhang, C. M. Koboldt, J. Muhammad, B. S. Zweifel, A. Shaffer, et al. 1998. Pharmacological analysis of cyclooxygenase-1 in inflammation. Proc. Natl. Acad. Sci. USA 95:13313-13318.
15. Vane, J. R. 1971. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin like drugs. Nat. New. Biol. 231:232-235.
16. Sachs, D., F. Q. Cunha, S. H. Ferreira. 2004. Peripheral analgesic blockade of hypernociception: activation of arginine/NO/cGMP/protein kinase G/ATP-sensitive K+ channel pathway. Proc. Natl. Acad. Sci. USA 101(10):3680-3685.
17. 2 as a mediator of fever: synthesis and catabolism. Front Biosci. 9:1977-1993.
18. Aronoff, D. M., and E. G. Neilson. 2001. Antipyretics: mechanisms of action and clinical use in fever suppression. Am. J. Med. 111:304-315.
19. Menezes, G. B., K. L. M. Maltos, J. M. M. Santos, I. D. G. Duarte, and J. N. Francischi. 2003. Cyclooxygenase (COX)-2 isoform accounts for neutrophilmigration in amodel of leukocyte recruitment induced by bacterial lipopolyssacaride in rats. Inflamm. Res. 52:S88.
20. Pereira, L. S. M., D. L. Ferreira-Alves, M. A. Resende, V. A. Romualdo, W. G. P. Reis, M. T. P. Lopes, et al. 2003. Reduced production of hyperalgesic substances by mononuclear cells from aged rats incubated with carrageenan: role of interleukin-2 and prostaglandins. Inflamm. Res. 52(3):119-125.
21. Giuliano, F., and T. D. Warner. 2002. Origins of prostaglandin E2: Involvements of cyclooxygenase (COX)-1 and COX 2 in human and rat systems. J. Pharmacol. Exp. Ther. 303:1001-1006.
22. Lauffenburger, D. A., and A. F. Horwitz. 1996. Cell migration: a physically integrated molecular process. Cell 84(3):359-369.
23. Vane, J. R., and R. M. Botting. 1997. Mechanism of action of aspirin-like drugs. Semin. Arthritis. Rheum. 26:2-10.
24. Warner, T. D., I. Vojnovic, F. Giuliano, R. Jiménez, D. Bishop-Bailey, and J. A. Mitchell. 2004. Cyclooxygenases 1, 2, and 3 and the production of prostaglandin I2: investigating the activities of acetaminophen and cyclooxygenase-2-selective inhibitors in rat tissues. J. Pharmacol. Exp. Ther. 310:642-647.
25. 4. Biochem. Pharmacol. 35:1709-1717.
26. 2 alpha on rat tissues. Prostaglandins, Leukot. Essent. Fat. Acids. 57:6527-6532.
27. Kammerl, M. C., J. Debler, G. A. Riegger, and B. K. Kramer. 2004. COX 2 inhibitors and risk of heart failure. Lancet. 364:1486-1487.
28. Topol, E. J. 2004. Failing the Public Health - Rofecoxib, Merck, and the FDA. N. Engl. J. Med. 351:1707-1709.